- Clinical charateristics of study groups.
Patients characteristics | GDM (n=40) | Control (n=42) | P-value |
---|---|---|---|
Age (years), mean±SD | 30.4±4.6 | 29.8±6.1 | 0.5972* |
Gravidity, n (range of birth) | 3 (1-4) | 2 (1-5) | 0.4076** |
Parity, n (range of birth) | 1 (0-4) | 1 (0-3) | 0.1593** |
Fasting blood glucose (mg/dL), mean±SD | 89.2±33.3 | 78±34.1 | 0.1413** |
Pregnancy age (weeks) | 38 weeks + 4 days | 39 weeks + 2 days | 0.1171** |
Fetal macrosomia† | 4 (10.0) | 1 (2.4) | 0.1520†† |
Preeclampsia‡ | 4 (10.0) | 2 (4.8) | 0.3655†† |
Neonatal hypoglycemia§ | 5 (12.5) | 2 (4.8) | 0.2128†† |
Fetal weight (g), mean±SD | 3437±522 | 3205±493 | 0.2424* |
Placental weight (g), mean±SD | 541.2±283.1 | 456.3±318.7 | 0.2055* |
Values are presented as number and precentage (%). †Fetal macrosomia is defined as birth weight >4000 g.25 ‡According to The American College of Obstetricians and Gynecologists Preeclampsia Guideline 2020.26 §According to American Academy of Pediatrics Neonatal Hypoglycemia Guideline.27 *Independent samples t-test, **Mann-Whitney test, ††Chi-squared test, GDM: gestational diabetes mellitus, SD: standard deviation